A unique role for p53 in the regulation of M2 macrophage polarization
L Li,D S W Ng,W-C Mah,F F Almeida,S A Rahmat,V K Rao,S C Leow,F Laudisi,M T Peh,A M Goh,J S Y Lim,G D Wright,A Mortellaro,R Taneja,F Ginhoux,C G Lee,P K Moore,D P Lane
DOI: https://doi.org/10.1038/cdd.2014.212
IF: 12.067
2014-12-19
Cell Death and Differentiation
Abstract:P53 is critically important in preventing oncogenesis but its role in inflammation in general and in the function of inflammatory macrophages in particular is not clear. Here, we show that bone marrow-derived macrophages exhibit endogenous p53 activity, which is increased when macrophages are polarized to the M2 (alternatively activated macrophage) subtype. This leads to reduced expression of M2 genes. Nutlin-3a, which destabilizes the p53/MDM2 (mouse double minute 2 homolog) complex, promotes p53 activation and further downregulates M2 gene expression. In contrast, increased expression of M2 genes was apparent in M2-polarized macrophages from p53-deficient and p53 mutant mice. Furthermore, we show, in mice, that p53 also regulates M2 polarization in peritoneal macrophages from interleukin-4-challenged animals and that nutlin-3a retards the development of tolerance to Escherichia coli lipopolysaccharide. P53 acts via transcriptional repression of expression of c-Myc (v-myc avian myelocytomatosis viral oncogene homolog) gene by directly associating with its promoter. These data establish a role for the p53/MDM2/c-MYC axis as a physiological ‘brake’ to the M2 polarization process. This work reveals a hitherto unknown role for p53 in macrophages, provides further insight into the complexities of macrophage plasticity and raises the possibility that p53-activating drugs, many of which are currently being trialled clinically, may have unforeseen effects on macrophage function.
cell biology,biochemistry & molecular biology